six
volunt
experienc
sever
inflammatori
respons
phase
clinic
trial
monoclon
antibodi
design
stimul
regulatori
cell
respons
soon
trial
began
volunt
experienc
cytokin
storm
dramat
increas
cytokin
concentr
monoclon
antibodi
rais
serum
concentr
proand
antiinflammatori
cytokin
hich
valu
first
day
lymphocyt
monocyt
concentr
plummet
subject
healthi
prior
indic
immun
defici
event
provid
unusu
opportun
studi
dynam
interact
cytokin
measur
paramet
respons
histori
nine
cytokin
model
set
linear
ordinari
differenti
equat
gener
search
procedur
identifi
paramet
model
whose
respons
fit
data
well
fiveday
measur
period
eighteenthord
model
reveal
plausibl
causeandeffect
relationship
among
cytokin
show
cytokin
induc
inhibit
cytokin
suggest
perturb
signific
induct
effect
ifnc
greatest
inhibit
effect
cytokin
concentr
although
tnfa
major
proinflammatori
factor
ifnc
three
cytokin
faster
initi
median
respons
infus
principalcompon
analysi
data
reveal
three
cluster
similar
cytokin
respons
tnfa
tnfa
highest
degre
variabl
respons
uncertain
initi
condit
exogen
effect
paramet
estim
studi
illumin
detail
cytokin
storm
event
demonstr
valu
linear
model
interpret
complex
coupl
biolog
system
dynam
empir
data
citat
yiu
hh
graham
al
stengel
rf
dynam
cytokin
storm
plo
one
cytokin
signal
peptid
protein
glycoprotein
secret
mani
cell
type
includ
immun
epitheli
endotheli
smooth
muscl
cell
either
enhanc
inhibit
inflamm
respons
pathogen
nonself
molecul
toxin
cytokin
allow
contextdepend
commun
within
bodi
interact
lead
cytokin
product
destabil
cytokin
storm
hypercytokinemia
result
produc
unbridl
inflamm
within
tissu
key
organ
cytokin
storm
associ
sepsi
septic
shock
influenza
acut
respiratori
distress
host
respons
blood
transfus
bone
marrow
transplant
toxic
respons
medic
implic
spanish
flu
pandem
sever
acut
respiratori
syndrom
sar
outbreak
avian
influenza
infect
first
recogn
activ
helper
regulatori
cell
normal
requir
two
signal
one
antigenmhc
complex
tcell
receptor
concurr
costimulatori
signal
cell
surfac
receptor
provid
antigenpres
cell
genet
engin
antibodi
agonist
activ
cell
without
costimulatori
antigen
signal
drug
manufactur
saw
potenti
applic
patient
chronic
lymphocyt
leukemia
whose
tcell
popul
destroy
chemotherapi
along
cancer
b
cell
also
saw
potenti
applic
boost
regulatori
cell
treat
autoimmun
inflammatori
diseas
rheumatoid
arthriti
effector
cell
becom
overact
pathogen
efficaci
demonstr
anim
model
phase
clinic
trial
schedul
test
human
march
six
healthi
male
volunt
receiv
two
volunt
receiv
placebo
great
care
taken
establish
dosag
deem
safe
human
within
hour
infus
six
receiv
drug
experienc
advers
effect
receiv
placebo
drug
recipi
headach
muscl
pain
nausea
diarrhea
decreas
blood
pressur
increas
heart
rate
indic
system
inflammatori
respons
syndrom
sir
sever
deplet
lymphocyt
monocyt
occur
four
hour
drug
infus
continu
fourth
day
creactiv
protein
serum
creatinin
neutrophil
concentr
increas
well
normal
level
time
period
eventu
six
patient
experienc
multiorgan
failur
infiltr
lung
intravascular
coagul
renal
failur
lung
injuri
critic
care
subsequ
treatment
includ
dialysi
mechan
ventil
one
case
surgeri
counter
peripher
ischemia
period
ill
extend
beyond
one
month
may
induc
perman
damag
patient
biolog
explan
event
offer
infect
underli
diseas
endotoxin
caus
uniqu
event
henc
allow
unusu
insight
cours
impact
immunemedi
cytokin
storm
analysi
present
particularli
focus
timedepend
coupl
interact
among
nine
cytokin
measur
abil
model
captur
dynam
suggest
nonlinear
complex
cytokin
storm
may
prove
insurmount
problem
mathemat
biologist
analyz
cytokin
level
collect
first
five
day
clinic
trial
dosag
mg
per
kg
bodi
mass
averag
kg
six
patient
drug
infus
rate
mgmin
averag
time
min
infus
time
short
compar
measur
interv
time
scale
respons
effect
differ
infus
durat
estim
deriv
dynam
model
sequel
patient
began
experi
advers
side
effect
clinician
treat
subject
corticosteroid
chlorpheniramin
acetaminophen
ondansetron
metaraminol
methylprednisolen
receptor
antagonist
antibodi
subject
receiv
aggress
individu
treatment
intens
care
consequ
record
cytokin
histori
reflect
natur
reaction
subject
respons
therapi
concentr
tumor
necrosi
factor
tnf
interferon
ifn
c
interleukin
il
measur
eight
hour
drug
infus
hour
postinfus
clinician
took
measur
everi
six
hour
day
daili
day
valu
linearli
interpol
point
tabul
interv
day
analysi
tnfa
ifnc
gener
character
proinflammatori
cytokin
antiinflammatori
cytokin
either
depend
signal
pathway
ordinari
differenti
equat
often
use
describ
popul
dynam
immun
cell
pathogen
signal
protein
present
linear
timeinvari
model
whose
paramet
estim
median
time
seri
data
six
clinic
subject
model
describ
evolut
nine
cytokin
concentr
without
regard
cell
secret
affect
cellular
sourc
sink
report
literatur
discuss
later
section
separ
secondord
equat
concentr
ratesofchang
cytokin
construct
bestfit
time
constant
found
numer
search
nine
cytokin
analyz
concurr
eighteenthord
system
unifi
search
higherord
system
paramet
improv
fit
measur
variabl
provid
integr
model
cytokin
storm
event
coupl
model
illustr
multiclass
interact
among
cytokin
identifi
respons
mode
mode
shape
ie
eigenvalu
eigenvector
reveal
similar
princip
compon
data
set
differentialand
differenceequ
model
numer
search
algorithm
describ
effect
uncertainti
initi
condit
exogen
effect
paramet
estim
evalu
use
stochast
extens
linear
model
normal
cytokin
concentr
rang
pgml
ifnc
pgml
less
sever
order
magnitud
maximum
shown
fig
point
identifi
measur
fig
median
valu
six
patient
referenc
baselin
infus
time
present
fig
interquartil
error
bar
often
span
measur
rang
also
shown
figur
supplementari
materi
show
consider
patienttopati
variat
cytokin
profil
signal
satur
limit
cytometr
bead
array
immunoassay
pgml
thu
higher
cytokin
valu
could
detect
individu
signal
frequent
reach
satur
limit
first
day
event
estim
sever
peak
cytokin
level
particularli
tnfa
ifnc
may
conserv
median
rather
mean
averag
six
individu
present
satur
would
bia
mean
comput
origin
data
growth
decay
individu
cytokin
respons
initi
state
first
repres
secondord
linear
timeinvari
ordinari
differenti
equat
denot
serum
concentr
x
rate
chang
x
acceler
cytokin
concentr
repres
vectormatrix
form
differenti
equat
express
state
vector
x
stabil
matrix
gener
form
initi
concentr
x
referenc
cytokin
basal
level
initi
rate
chang
x
stimul
infus
b
posit
constant
express
sensit
cytokin
acceler
x
concentr
rate
chang
analysi
b
x
determin
leastsquar
fit
trial
median
respons
effect
clinic
treatment
subsum
valu
b
cytokin
respons
mode
character
eigenvalu
l
l
radday
root
characterist
equat
consequ
eq
express
realvalu
eigenvalu
respons
time
constant
day
neg
invers
l
l
two
respons
mode
reflect
exponenti
growth
decay
eigenvalu
complex
root
complex
conjug
jv
defin
singl
mode
respons
natur
frequenc
v
n
damp
ratio
f
period
p
respect
ffiffi
ffi
p
ffiffi
ffi
p
n
f
mode
underdamp
oscillatori
eigenvector
e
describ
rel
respons
state
element
mode
defin
l
solut
n
th
order
equat
n
secondord
model
equat
multipli
arbitrari
constant
without
chang
equal
absolut
magnitud
phase
e
signific
secondord
system
eq
eigenvector
express
system
differenti
equat
convert
differ
equat
facilit
paramet
identif
state
propag
one
sampl
instant
k
next
use
statetransit
matrix
w
dt
dtt
k
w
dt
adt
henc
equat
equival
e
adt
invers
laplac
transform
si
secondord
differ
equat
express
extrapol
eq
exact
ident
continuoustim
model
lost
therefor
discretetim
model
employ
numer
search
b
x
equival
l
l
x
model
paramet
chosen
minim
error
cytokin
concentr
propag
eq
x
k
clinic
trial
measur
z
k
posit
neg
error
equal
unaccept
henc
positivedefinit
quadrat
cost
j
sum
squar
error
e
k
interv
appropri
metric
j
minim
use
downhil
simplex
neldermead
algorithm
implement
matlab
fminsearch
iter
cytokin
model
termin
error
cost
fall
accept
toler
defin
default
set
matlab
algorithm
function
minim
eq
cytokin
gener
nine
set
l
l
x
tabl
initi
rate
chang
concentr
repres
cytokin
respons
drug
input
eigenvalu
neg
henc
mode
stabl
five
proinflammatori
cytokin
fastest
respond
infus
time
constant
respons
rang
day
respons
also
model
critic
overdamp
oscil
f
period
p
day
eigenvector
mode
determin
inspect
tabl
eq
uncoupl
cytokin
model
fit
measur
cytokin
respons
reason
well
fig
reveal
noth
cytokin
interact
model
concentr
peak
within
day
decay
rate
data
fit
error
pronounc
peak
tnfa
tail
tnfa
ifnc
concentr
order
magnitud
smaller
cytokin
model
allow
us
predict
respons
unit
initialcondit
concentr
rate
chang
model
linear
respons
shape
independ
initialcondit
magnitud
unit
drug
infus
model
impuls
forc
produc
initi
rate
chang
cytokin
fig
given
equal
start
point
ifnc
rate
quickest
rise
decay
achiev
lowest
concentr
peak
slowest
respond
reach
highest
peak
concentr
linger
four
day
ifnc
respons
essenti
two
day
decay
cytokin
product
rate
correl
decreas
measur
tcell
monocyt
popul
predict
respons
increment
chang
cytokin
concentr
shown
fig
rel
speed
magnitud
respons
unchang
howev
presenc
two
exponenti
mode
less
obviou
neg
rate
chang
peak
first
day
concentr
decay
smoothli
zero
uncoupl
stabil
matrix
individu
cytokin
model
provid
start
point
creat
singl
coupl
model
respons
broad
descript
system
dynam
eq
unchang
dimens
state
vector
stabil
matrix
state
transit
matrix
increas
cytokin
repres
state
vector
concentr
rate
chang
odd
compon
x
k
concentr
even
compon
x
k
rate
chang
dim
x
cytokin
coupl
blockdiagon
coeffici
identifi
individu
model
correspond
state
transit
matrix
w
dt
uc
denot
uncoupl
stabil
matrix
dt
hr
state
transit
matrix
eq
propag
state
vector
evalu
error
cost
j
begin
zero
concentr
rate
chang
present
tabl
error
cost
j
defin
z
k
vector
clinic
measur
k
x
c
k
vector
cytokin
concentr
predict
model
ie
even
compon
x
k
e
k
differ
time
point
diagon
matrix
q
normal
cytokin
residu
give
equival
weight
cost
function
approach
confirm
appli
search
algorithm
identifi
uncoupl
eighteenthord
model
uc
minim
reproduc
eigenvalu
initi
rate
chang
tabl
least
signific
digit
cytokin
coupl
offdiagon
block
contain
concentr
sensit
coeffici
lowerleft
element
fix
initi
rate
chang
previou
valu
tabl
cost
function
minim
respect
paramet
l
l
paramet
diagon
block
coupl
paramet
neldermead
algorithm
robust
guarante
find
local
minimum
cost
function
positivedefinit
quadrat
cost
function
lti
dynam
constraint
theoret
possess
one
global
minimum
local
minima
may
aris
numer
imprecis
eg
finit
word
length
round
truncat
comput
local
minima
may
far
remov
global
minimum
unconstrain
cost
function
eq
assur
minim
defin
coupl
stabil
matrix
c
neighborhood
uc
assign
small
penalti
sum
squar
offdiagon
paramet
procedur
call
regular
wide
use
statist
machin
learn
denot
coupl
paramet
vector
p
c
soft
constraint
weight
r
c
ad
error
cost
larg
valu
r
c
forc
p
c
zero
produc
paramet
vector
uncoupl
minim
penalti
weight
reduc
signific
coupl
paramet
reveal
penalti
sever
order
magnitud
smaller
error
cost
specifi
eq
p
c
estim
stabil
becom
insensit
valu
r
c
minim
reduc
error
cost
howev
trace
estim
c
higher
trace
uc
trace
equal
neg
sum
eigenvalu
call
total
damp
system
coupl
paramet
redistribut
eigenvalu
chang
total
damp
system
model
therefor
penal
squar
differ
trace
uc
c
augment
error
cost
function
r
small
coeffici
trace
penalti
sever
order
magnitud
smaller
fiterror
cost
minimum
use
differ
trace
reduc
less
fiterror
cost
lower
addit
odd
column
even
row
c
portray
sensit
cytokin
respons
cytokin
concentr
present
concentr
coeffici
matrix
c
c
tabl
diagon
element
reduc
matrix
neg
indic
stabl
selfregul
cytokin
sens
magnitud
coupl
effect
one
cytokin
anoth
given
offdiagon
element
even
diagon
term
c
neg
provid
damp
coupl
system
induct
inhibit
effect
readili
visual
fig
illustr
three
highestmagnitud
coupl
path
cytokin
well
selfinhibit
cytokin
three
twoway
path
figur
tnfa
mutual
inhibit
enhanc
inhibit
ifnc
tnfa
ifnc
involv
six
strong
coupl
pathway
particip
seven
three
largest
effect
induct
three
largest
effect
inhibitori
coupl
respons
unit
initi
condit
shown
fig
cytokin
concentr
decay
excit
respons
remain
cytokin
whose
initi
valu
taken
zero
clariti
signific
coupl
shown
nevertheless
simul
includ
cytokin
coupl
effect
appar
coupl
small
signific
proinflammatori
cytokin
tnfa
induc
proinflammatori
cytokin
downregul
antiinflammatori
one
convers
perturb
inhibit
tnfa
stimul
cytokin
exhibit
differ
time
scale
respons
peak
other
eg
respons
interplay
among
cytokin
demonstr
fig
initi
cytokin
plot
vertic
z
axi
two
highli
perturb
cytokin
plot
horizont
x
axe
thu
initi
condit
plot
five
day
state
approach
symbol
repres
accept
pro
anti
mixedinflammatori
classif
cytokin
statespac
plot
portray
motif
signific
cytokin
respons
three
cytokin
respond
similar
time
scale
curv
round
time
scale
significantli
differ
curv
contain
hairpin
kink
exampl
initi
perturba
estim
stabil
matrix
c
possess
four
real
seven
complex
mode
tabl
list
mode
order
increas
eigenvalu
magnitud
present
three
signific
eigenvector
compon
magnitud
mode
well
period
damp
ratio
oscillatori
mode
cytokin
present
eigenvector
howev
third
largest
eigenvector
compon
typic
much
smaller
first
two
oscillatori
mode
heavili
damp
two
pair
mode
nearli
ident
period
differ
smaller
eigenvector
compon
neither
tnfa
ifnc
largest
compon
mode
although
rank
second
third
sever
case
appear
third
compon
mode
ifnc
equal
repres
mode
ifnc
equal
represent
mode
suggest
cytokin
involv
intercytokin
coupl
mode
deriv
princip
mode
larg
due
compar
result
tabl
seen
least
impact
intercytokin
coupl
princip
compon
assess
similar
wave
shape
nine
cytokin
histori
show
orthogon
project
origin
data
base
singularvalu
decomposit
covari
matrix
f
unlik
modal
analysi
present
princip
compon
address
causal
coupl
dynam
variabl
drawn
togeth
common
stimulu
x
princip
compon
vector
k
express
c
squar
matrix
deriv
singular
valu
z
transform
data
z
k
orthogon
compon
k
associ
largest
singular
valu
z
henc
describ
largest
variabl
data
set
k
describ
next
highest
present
case
first
princip
compon
correl
cytokin
respons
next
two
compon
account
correl
fig
remain
six
princip
compon
describ
respons
shape
similar
cytokin
exhibit
singl
peak
growth
decay
k
variat
across
sampl
produc
twoand
threepeak
wave
found
k
k
first
three
row
c
contain
coeffici
largest
princip
compon
fig
figur
show
coeffici
far
remov
eight
cytokin
two
coeffici
set
tnfa
overli
figur
close
connot
similar
wave
shape
threedimension
depict
ambigu
ambigu
elimin
comput
distanc
coeffici
triplet
link
close
tree
dendrogram
fig
cytokin
group
accord
distanc
height
link
indic
distanc
dendrogram
reveal
tnfa
respons
inde
close
respons
similar
ifnc
form
second
cluster
also
includ
separ
rest
group
becom
appar
model
cytokin
respons
fig
see
tnfa
concentr
quit
close
similar
shape
lower
amplitud
group
ifnc
similar
group
b
faster
respons
first
group
class
slow
respons
group
c
proinflammatori
cytokin
appear
group
b
ifnc
faster
group
faster
antiinflammatori
cytokin
mixedcategori
cytokin
appear
fastest
slowest
group
mathemat
model
cytokinestorm
respons
allow
us
investig
sever
addit
topic
take
advantag
clinic
trial
data
model
use
studi
effect
inhibit
individu
cytokin
predict
effect
differ
infus
rate
reveal
effect
empir
uncertainti
analys
base
linear
model
specif
event
median
cytokin
concentr
driven
immun
respons
also
benefici
treatment
intens
care
consider
variat
respons
trial
six
subject
effect
inhibit
individu
cytokin
reveal
solv
dynam
equat
eq
requisit
row
c
eq
set
zero
exampl
zero
first
two
row
elimin
effect
tnfa
cancel
individu
effect
provid
assess
signific
miss
variabl
dynam
coupl
remain
eight
cytokin
examin
miss
cytokin
two
set
proinflammatori
cytokin
figur
show
elimin
tnfa
weak
effect
littl
effect
cytokin
result
suggest
tnfa
concentr
drive
factor
dynam
cytokin
network
surpris
given
variabl
role
tnfa
immun
cell
biolog
lack
ifnc
induc
signific
chang
inhibit
caus
reach
higher
peak
decay
slowli
lose
produc
oscillatori
respons
inhibit
antiinflammatori
cytokin
produc
small
effect
neglig
effect
proinflammatori
cytokin
fig
loss
affect
sever
cytokin
slow
decay
tnfa
increas
decay
ifnc
produc
oscillatori
respons
result
suggest
sustain
presenc
clinic
trial
strong
effect
cytokin
elimin
significantli
impact
cytokin
part
respons
order
magnitud
smaller
other
respons
stimulu
model
explicitli
ad
forc
term
dynam
equat
subsum
previou
initi
rate
chang
term
infus
rate
repres
u
affect
cytokin
propag
matrix
b
odd
element
b
zero
even
element
deriv
estim
initi
rate
tabl
assum
clinic
infus
last
min
occur
mgmin
mgday
b
x
maintain
fix
dose
mg
infus
rate
invers
proport
infus
durat
infus
see
result
increas
infus
durat
minut
day
fig
pharmacokinet
effect
neglect
simul
virtual
ident
result
instantan
infus
littl
chang
profil
durat
last
sever
hour
shown
oneday
infus
durat
rate
mg
min
sever
cytokin
peak
remain
close
record
valu
signific
reduct
peak
valu
requir
infus
period
day
infus
rate
trial
valu
howev
stretch
infus
period
prolong
period
cytokin
concentr
remain
unaccept
high
level
model
suggest
reduc
infus
rate
increas
infus
period
would
attenu
prevent
cytokin
storm
observ
cytokin
concentr
structuredbutrandom
variabl
vari
one
patient
next
within
patient
cytokin
level
influenc
mani
signal
serum
concentr
expos
local
distribut
within
bodi
error
occur
sampl
analysi
measur
snapshot
rather
continu
observ
consequ
never
know
cytokin
concentr
determinist
accuraci
best
estim
probabl
distribut
concentr
rate
probabl
distribut
whether
gaussian
character
second
order
mean
covari
examin
propag
variabl
system
equat
deriv
sec
mean
vector
covari
matrix
p
ensembl
multidimension
random
variabl
x
x
pr
x
pr
x
probabl
densiti
function
x
e
denot
expect
valu
argument
expect
valu
propag
time
dynam
model
given
initi
condit
known
input
equat
determinist
equat
x
b
u
known
exactli
gener
expect
mean
valu
x
x
actual
initi
condit
unknown
mean
valu
x
x
u
random
u
known
stochast
differenti
equat
timevari
mean
cytokin
mean
vector
propag
discret
interv
time
dt
cytokin
covari
propag
expect
outer
product
eq
uncertain
forc
covari
matrix
estim
p
k
depend
initi
condit
diagon
element
p
k
estim
varianc
x
k
squar
root
correspond
standard
deviat
k
n
x
k
k
unit
plot
x
k
k
vs
k
would
produc
envelop
contain
probabl
respons
random
variabl
gaussian
choos
p
diagon
matrix
allow
us
estim
initi
uncertainti
cytokin
rate
would
propag
cytokin
storm
fig
exampl
assum
comput
interv
dt
day
unit
initi
varianc
concentr
zero
even
element
one
odd
element
p
standard
deviat
decay
seen
fig
unit
initi
rate
varianc
zero
odd
element
one
even
element
p
produc
concentr
standard
deviat
shown
fig
equat
linear
x
k
p
k
standard
deviat
respons
similar
ident
cytokin
mean
valu
respons
fig
initi
uncertainti
il
slowest
decay
ifnc
fastest
assess
effect
continu
random
forc
cytokin
element
eg
unspecifi
immunolog
respons
add
disturb
covari
w
eq
set
initi
error
covari
matrix
zero
illustr
w
taken
diagon
forc
matrix
zero
odd
element
one
even
element
cytokin
standard
deviat
reach
steadi
valu
sever
day
fig
model
quasihomeostat
differ
cytokin
level
ratio
level
interest
loos
relat
stimul
concentr
show
largest
continu
uncertainti
ifnc
lowest
small
random
uncertainti
stabil
matrix
coeffici
assess
within
format
effect
unit
varianc
damp
element
c
shown
fig
follow
disturb
covari
w
k
take
form
l
k
contain
element
x
k
f
main
diagon
w
diagon
matrix
one
even
term
zero
odd
term
assum
paramet
uncertainti
typic
nomin
paramet
valu
henc
respons
effect
pronounc
three
uncertainti
exampl
figur
show
tnfa
higher
respons
paramet
uncertainti
less
clinic
trial
provid
narrow
window
assess
causal
coordin
associ
cytokin
druginduc
storm
allow
us
assess
rel
respons
nine
import
signal
molecul
infer
interregulatori
effect
cytokin
concentr
expect
respond
via
cellular
intermediari
stimulu
aggress
immunosuppress
treatment
patient
receiv
coupl
effect
among
cytokin
cytokin
respons
induc
treatment
separ
present
data
howev
coupl
among
cytokin
sensit
dynam
remov
individu
cytokin
nonetheless
explor
cytokin
associ
princip
immun
system
also
link
epitheli
endotheli
cell
smooth
muscl
adipos
tissu
thu
surpris
clinic
sign
includ
headach
muscl
pain
nausea
diarrhea
vasodil
hypotens
recruit
immun
cell
secret
cytokin
cytokin
regul
cellular
activ
thu
interest
examin
possibl
underli
cellular
relationship
cytokin
profil
addit
laboratori
result
shown
compar
princip
compon
cytokin
respons
cytokin
group
b
ifnc
fastest
respons
fig
peak
six
hour
tgn
infus
time
cell
monocyt
platelet
concentr
crash
cytokin
product
depend
concentr
cell
secret
well
percel
secret
rate
sudden
burst
cytokin
product
activ
cell
could
lead
apoptot
death
reduc
cell
popul
group
b
cytokin
return
near
basal
level
two
day
point
cell
recov
normal
valu
neutrophil
profil
reminisc
slower
group
c
respons
peak
day
infus
model
neutrophil
concentr
remain
upper
refer
rang
day
respons
system
damag
caus
event
growth
decay
serum
creatinin
elev
renal
dysfunct
occur
time
scale
parallel
group
tnfa
respons
creactiv
protein
concentr
strong
indic
inflamm
peak
day
infus
slower
time
scale
cytokin
group
return
normal
level
day
event
cell
secret
subject
cytokin
regul
list
tabl
denot
secret
r
indic
regul
tabl
base
literatur
search
cell
innat
adapt
immun
system
involv
phase
cytokin
storm
induc
proinflammatori
member
fast
group
b
identifi
interact
adapt
cell
associ
innat
immun
system
monocyt
macrophag
neutrophil
dendrit
mast
cell
well
sever
tissu
group
indic
cytokin
secret
neutrophil
except
associ
innat
immun
cell
tissu
type
underrepres
group
b
appear
primarili
slower
group
c
insight
cytokin
dynam
could
gain
addit
empir
trial
involv
drug
use
treat
cytokin
storm
drug
corticosteroid
chlorpheniramin
acetaminophen
ondansetron
metaraminol
methylprednisolen
receptor
antagonist
antibodi
could
administ
safe
healthi
subject
low
dosag
short
period
time
cytokin
concentr
would
measur
regular
interv
analysi
present
paper
could
appli
data
ancillari
data
includ
clinic
metric
could
collect
process
unlik
pharmacolog
clinic
trial
focus
safeti
efficaci
new
drug
empir
trial
would
direct
gain
new
knowledg
fundament
biolog
cross
comparison
would
allow
cytokin
coupl
effect
distinguish
direct
effect
drug
stimuli
secur
wellcontrol
environ
approach
could
lead
way
toward
develop
strong
theoret
basi
understand
cytokin
storm
explain
mani
aspect
human
physiolog
cytokin
storm
event
produc
clinic
trial
simul
well
eighteenthord
linear
timeinvari
dynam
system
cytokin
respons
assum
proport
current
concentr
current
rate
chang
thu
respons
repres
secondord
differenti
equat
nine
interact
cytokin
therefor
repres
eighteenthord
system
coeffici
model
found
minim
error
cost
function
use
downhillsimplex
method
system
model
provid
evid
regul
cytokin
cytokin
identifi
induct
inhibit
relationship
among
nine
cytokin
well
similar
tempor
histori
present
analysi
illustr
reduc
dosag
rate
increas
durat
infus
ie
fix
total
dosag
would
littl
effect
peak
cytokin
concentr
infus
durat
exceed
one
day
effect
would
benefici
period
cytokin
unaccept
high
level
also
would
increas
suggest
drug
dose
use
trial
crux
problem
analysi
data
princip
compon
reveal
cytokin
respons
profil
fall
three
group
tnfa
ifnc
associ
cytokin
cellular
secret
regul
suggest
adapt
immun
system
domin
effect
cytokin
storm
perhap
unsurpris
given
sourc
stimulu
suggest
literatur
review
proinflammatori
cytokin
like
produc
innat
system
cell
nonimmun
tissu
paper
present
sequenc
gener
analyt
procedur
use
interpret
tempor
biomed
data
wide
varieti
system
time
constant
natur
frequenc
damp
ratio
mode
shape
respons
mode
estim
respons
initi
condit
clinic
trial
predict
stochast
effect
assess
envis
extens
analysi
empir
biolog
trial
use
safe
pharmaceut
agent
stimul
dynam
respons
could
establish
new
paradigm
mathemat
theori
biolog
